Aimei Health Technology Co., Ltd (AFJK)
NASDAQ: AFJK · Real-Time Price · USD
8.00
-0.02 (-0.25%)
At close: Dec 5, 2025, 4:00 PM EST
8.14
+0.14 (1.75%)
After-hours: Dec 5, 2025, 5:32 PM EST
Company Description
Aimei Health Technology Co., Ltd does not have significant operations.
The company intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses.
It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector.
Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Aimei Health Technology Co., Ltd
| Country | United States |
| Founded | 2023 |
| IPO Date | Dec 4, 2023 |
| Industry | Shell Companies |
| Sector | Financials |
| CEO | Junheng Xie |
Contact Details
Address: 10 East 53rd Street, Suite 3001 New York, New York 10022 United States |
Stock Details
| Ticker Symbol | AFJK |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $10.00 |
| CIK Code | 0001979005 |
| CUSIP Number | G01341109 |
| ISIN Number | KYG013411098 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Junheng Xie | Chief Executive Officer, Secretary and Director |
| Heung Ming Wong | Chief Financial Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 2, 2025 | 8-K | Current Report |
| Nov 18, 2025 | 10-Q | Quarterly Report |
| Nov 14, 2025 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
| Nov 12, 2025 | 8-K | Current Report |
| Nov 10, 2025 | DEF 14A | Other definitive proxy statements |
| Nov 7, 2025 | SCHEDULE 13G/A | Filing |
| Nov 4, 2025 | 8-K | Current Report |
| Oct 29, 2025 | PRE 14A | Other preliminary proxy statements |
| Oct 10, 2025 | DEF 14A | Other definitive proxy statements |
| Oct 9, 2025 | 8-K | Current Report |